Inventor
SCHILLER SHAWN E R
US30 patents
⚠️ This page may combine multiple inventors who share the name “SCHILLER SHAWN E R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
22 patentsUS10336722B2Jul 2, 2019
Tetrahydroquinoline compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC22 citations93
US9422281B2Aug 23, 2016
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC25 citations93
US9388161B2Jul 12, 2016
Tetrahydroquinoline compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC34 citations93
US10472342B2Nov 12, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC4 citations84
US10399951B2Sep 3, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC5 citations84
US11111229B2Sep 7, 2021
Tetrahydroquinoline compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC4 citations83
US10611750B2Apr 7, 2020
Tetrahydroquinoline compositions as bet bromodomain inhibitors
FORMA THERAPEUTICS INC7 citations83
US10377769B2Aug 13, 2019
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC10 citations83
US10870648B2Dec 22, 2020
Inhibiting CREB binding protein (CBP)
FORMA THERAPEUTICS INC8 citations82
US10995078B2May 4, 2021
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC1 citations73
US10457655B2Oct 29, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC3 citations73
US10450286B2Oct 22, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC3 citations73
US10703764B2Jul 7, 2020
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC2 citations72
US11254674B2Feb 22, 2022
Inhibiting CREB binding protein (CBP)
FORMA THERAPEUTICS INC2 citations71
US11084831B1Aug 10, 2021
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC0 citations62
US10913753B2Feb 9, 2021
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
FORMA THERAPEUTICS INC2 citations61
US12378242B2Aug 5, 2025
Inhibiting CREB binding protein (CBP)
FORMA THERAPEUTICS INC0 citations60
US11787803B2Oct 17, 2023
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
FORMA THERAPEUTICS INC0 citations60
US11292791B2Apr 5, 2022
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
FORMA THERAPEUTICS INC1 citations60
US11267805B2Mar 8, 2022
Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone
FORMA THERAPEUTICS INC0 citations59
US10800750B2Oct 13, 2020
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC0 citations52
US12351577B2Jul 8, 2025
Inhibiting cyclic AMP-responsive element-binding protein (CREB)
FORMA THERAPEUTICS INC0 citations50
FOGHORN THERAPEUTICS INC
5 patentsUS11497752B2Nov 15, 2022
Compounds and uses thereof
FOGHORN THERAPEUTICS INC7 citations84
US12383560B2Aug 12, 2025
Compounds and uses thereof
FOGHORN THERAPEUTICS INC1 citations63
US12441726B2Oct 14, 2025
Compounds and uses thereof
FOGHORN THERAPEUTICS INC1 citations59
US12139487B2Nov 12, 2024
Compounds and uses thereof
FOGHORN THERAPEUTICS INC1 citations55
US12509453B2Dec 30, 2025
BRM/BRG1 inhibitors and uses thereof
FOGHORN THERAPEUTICS INC0 citations50